C Mauz-Körholz

Author PubWeight™ 18.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevalence and outcome of intracranial haemorrhage in haemophiliacs--a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH). Eur J Pediatr 1999 1.24
2 Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 1993 1.07
3 Allo-SCT using BU, CY and melphalan for children with AML in second CR. Bone Marrow Transplant 2012 0.85
4 The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies. Klin Padiatr 2004 0.83
5 General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases. Histol Histopathol 2012 0.83
6 High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity. Klin Padiatr 2012 0.82
7 Detection of antiphospholipid antibodies in children and adolescents. Pediatr Hematol Oncol 1998 0.80
8 The role of interleukin-10 (IL-10) in IL-15-mediated T-cell responses. Blood 1997 0.80
9 Primary chemotherapy and conservative surgery for vaginal yolk-sac tumour. Maligne Keimzelltumoren Study Group. Lancet 2000 0.79
10 TRAIL-induced cytotoxicity in a melphalan-resistant rhabdomyosarcoma cell line via activation of caspase-2. Anticancer Res 2006 0.79
11 Management of oncology patients admitted to the paediatric intensive care unit of a general children's hospital - a single center analysis. Klin Padiatr 2011 0.79
12 [Immune tolerance induction with high-dose FVIII and pulsed intravenous immunoglobulin]. Hamostaseologie 2010 0.79
13 Interleukin 10 induced c-fos expression in human B cells by activation of divergent protein kinases. Immunol Invest 1996 0.78
14 Molecular mechanisms and gene regulation of melphalan- and hyperthermia-induced apoptosis in Ewing sarcoma cells. Anticancer Res 2008 0.78
15 Transforming growth factor-beta1 suppresses interleukin-15-mediated interferon-gamma production in human T lymphocytes. Scand J Immunol 1999 0.78
16 The EuroNet paediatric hodgkin network - modern imaging data management for real time central review in multicentre trials. Klin Padiatr 2013 0.78
17 Methylenetetrahydrofolate reductase gene polymorphism and glucocorticoid intake in children with ALL and aseptic osteonecrosis. Klin Padiatr 2003 0.77
18 Interleukin-10 directly inhibits the interleukin-6 production in T-cells. Scand J Immunol 1995 0.77
19 Endogenous pro-inflammatory cytokines in children and adolescents during chemotherapy-induced neutropenia. Pediatr Hematol Oncol 2002 0.77
20 Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma. Klin Padiatr 2012 0.76
21 Regulation of interleukin-2 induced interleukin-5 and interleukin-13 production in human peripheral blood mononuclear cells. Scand J Immunol 2000 0.76
22 Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors. Haemophilia 1999 0.76
23 Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL). Klin Padiatr 2012 0.76
24 Humoral immunodeficiency in patients after bone marrow transplantation. Bone Marrow Transplant 1996 0.76
25 Activation of protein kinase C induces de novo synthesis of the soluble interleukin-6 receptor in human B cells. Scand J Immunol 1994 0.75
26 G-CSF and liver toxicity in a patient with neuroblastoma. Lancet 1992 0.75
27 [FDG-PET in Hodgkin lymphoma]. Nuklearmedizin 2008 0.75
28 Humoral coagulation and early complications after allogeneic bone marrow transplantation. Klin Padiatr 1997 0.75
29 Determination of terephthalic acid isopropylamide in urine with a liquid chromatography/mass spectrometry (LC/MS) method. J Clin Lab Anal 2008 0.75
30 Whole body thermochemotherapy in an infant with rhabdomyosarcoma and pulmonary metastases. Med Pediatr Oncol 2003 0.75
31 How to Overcome Scientific Standstill for Very Rare Diseases: Clinical Trials or Clinical Registries? Klin Padiatr 2015 0.75
32 Molecular biology and clinical manifestation of hereditary factor VII deficiency. Semin Thromb Hemost 2000 0.75
33 Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy. Klin Padiatr 2014 0.75
34 Acute psychosis in an adolescent girl during treatment for advanced nodular lymphocyte-predominant Hodgkin's lymphom. Klin Padiatr 2011 0.75
35 Co-operation of IL-1 and IL-2 on T-cell activation in mononuclear cell cultures. Immunol Invest 2001 0.75
36 Prognostic value of T-1 cell numbers prior to allogeneic stem cell transplantation in patients with severe graft-versus-host disease. Bone Marrow Transplant 2005 0.75